John Najim
Direttore Tecnico/Scientifico/R&S presso DYNE THERAPEUTICS, INC.
Profilo
John Najim is currently the Chief Technical Officer at Dyne Therapeutics, Inc. Prior to his current position, he worked as an Associate Director-Manufacturing at Dyax Corp.
and as the VP-Manufacturing & Process Development at Proteon Therapeutics, Inc. from 2009 to 2019.
Mr. Najim holds an MBA from Bentley University and an undergraduate degree from Merrimack College.
Posizioni attive di John Najim
| Società | Posizione | Inizio |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2019 |
Precedenti posizioni note di John Najim
| Società | Posizione | Fine |
|---|---|---|
| PROTARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2019 |
| DYAX CORP. | Corporate Officer/Principal | - |
Formazione di John Najim
| Merrimack College | Undergraduate Degree |
| Bentley University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. BiotechnologyHealth Technology Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
- Borsa valori
- Insiders
- John Najim
